2023
The Choice of Anticoagulant at First Recurrence Does Not Alter the Risk for the Second Recurrence
Muradashvili T, Restrepo V, Alameddine D, Soliman S, Feinn R, Chaar C, Lee A, Pine A. The Choice of Anticoagulant at First Recurrence Does Not Alter the Risk for the Second Recurrence. Blood 2023, 142: 5540. DOI: 10.1182/blood-2023-191084.Peer-Reviewed Original ResearchFirst VTE recurrenceDeep venous thrombosisFirst venous thromboembolismRecurrent VTE eventsVTE recurrenceVenous thromboembolismPulmonary embolismAnticoagulation regimenVTE eventsAnticoagulant regimenFirst recurrenceINR targetSecond recurrenceExact testFirst recurrent venous thromboembolismInferior vena cava atresiaLarge tertiary academic hospitalUnprovoked first venous thromboembolismMajor public health hazardDifferent anticoagulant agentsInterruption of anticoagulationCardiovascular risk factorsMay-Thurner syndromePatients 18 yearsRecurrent venous thromboembolism
2017
Anticoagulation for Proximal Deep Vein Thrombosis
Lee A, Lee E. Anticoagulation for Proximal Deep Vein Thrombosis. 2017, 299-313. DOI: 10.1007/978-3-319-65226-9_23.Peer-Reviewed Original ResearchDeep vein thrombosisVenous thromboembolismPulmonary emboliVein thrombosisProximal deep vein thrombosisMonths of anticoagulationProvoked venous thromboembolismUnprovoked venous thromboembolismEstimates of recurrenceLow recurrence riskRisk prediction modelExtended anticoagulationSurveillance ultrasonographyVTE eventsSuch patientsD-dimerSignificant morbidityThrombotic riskRisk factorsThrombophilia testingHigh riskAnticoagulationThrombosisRecurrenceRisk